BIOCIENCIAS: Bª Y CLÍNICA DEL CÁNCER Y MEDIC. TRASLACIONAL
Escuela de doctorado
Helsinki University Central Hospital
Helsinki, FinlandiaPublicaciones en colaboración con investigadores/as de Helsinki University Central Hospital (15)
2023
-
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
Haematologica
-
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294
2022
-
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Blood, Vol. 140, Núm. 11, pp. 1200-1228
-
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
Bone Marrow Transplantation
2021
-
Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT
Bone Marrow Transplantation, Vol. 56, Núm. 9, pp. 2194-2202
-
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380
2016
-
Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first-line immunochemotherapy in the PRIMA trial
Journal of Clinical Oncology, Vol. 34, Núm. 22, pp. 2575-2582
2015
-
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Nature Genetics, Vol. 47, Núm. 2, pp. 164-171
2011
2006
-
Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia
Journal of the National Cancer Institute, Vol. 98, Núm. 4, pp. 273-284
2005
2003
-
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
Blood, Vol. 102, Núm. 8, pp. 3043-3051
-
Matrix Metalloproteinase-21 Is Expressed Epithelially during Development and in Cancer and Is Up-Regulated by Transforming Growth Factor-β1 in Keratinocytes
Laboratory Investigation, Vol. 83, Núm. 12, pp. 1887-1899
2002
-
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia
Blood, Vol. 100, Núm. 12, pp. 3877-3886